ROVI is a Madrid-based pharmaceutical manufacturer operating since 1946, now modernizing its backend infrastructure around containerization (Kubernetes, Docker, Helm) and cloud platforms (AWS, Azure, GCP). The tech stack reveals an engineering org transitioning from legacy monoliths toward microservices—evidenced by active work on HL7/DICOM healthcare integrations, real-time biomedical image processing, and test automation pipelines. Hiring remains weighted toward sales and manufacturing roles, with a decelerating velocity suggesting the company is consolidating a platform rebuild rather than scaling headcount.
ROVI manufactures pharmaceutical products, performs contract manufacturing for third parties, and distributes licensed drugs across 88 countries via 22 international partners. The company's primary therapeutic focus includes Bemiparin, a drug in pre-registration through marketing stages globally. Operations span R&D, manufacturing, quality assurance, and sales teams distributed across Spain and Italy. Internal challenges center on hospital channel strategy, legacy backoffice modernization, and QA rigor—pain points the company is addressing through new sales processes, test automation, and healthcare system standardization work.
ROVI uses Kubernetes, Docker, Jenkins, and Helm for containerized ops; PostgreSQL for data; AWS, Azure, and GCP for cloud; Python, C++, and FastAPI for application development; Prometheus and Grafana for monitoring; and HL7/DICOM for medical data interchange.
Active projects include real-time biomedical image processing microservices, healthcare system integrations with HL7/DICOM standards, test automation in CI/CD pipelines, medical image viewer development with OpenLayers, and hospital sales action planning and drug introduction workflows.
Other companies in the same industry, closest in size